EMA — authorised 31 December 2009
- Application: EMEA/H/C/000930
- Marketing authorisation holder: Bristol-Myers Squibb Pharma EEIG
- Local brand name: Ixempra
- Status: withdrawn
🇪🇺 Ixabepilone (Ixempra) in European Union
EMA authorised Ixabepilone (Ixempra) on 31 December 2009
Marketing authorisation
Other Oncology approved in European Union
Frequently asked questions
Is Ixabepilone (Ixempra) approved in European Union?
Yes. EMA authorised it on 31 December 2009.
Who is the marketing authorisation holder for Ixabepilone (Ixempra) in European Union?
Bristol-Myers Squibb Pharma EEIG holds the EU marketing authorisation.